RECENT NEWS

New research led by scientists at California’s La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus therapeutics.

International researchers have warned that the ongoing mpox outbreak in the Democratic Republic of the Congo (DRC) has the potential to spread across borders more rapidly. The mpox virus has mutated, and the new variant, clade 1b, has become more infectious.

Twenty-five new National Institute for Health and Care Research (NIHR) Global Health Research Groups have been awarded funding under the programme’s Group 4 Call to deliver high-quality applied global health research and training in low and middle income countries (LMICs) over the next four years.

SBRI Healthcare, an Accelerated Access Collaborative (AAC) initiative, in partnership with the Health Innovation Network, has awarded £1 million for the development of 11 innovations that improve infection prevention and control to prevent the spread of antimicrobial resistance.

A new study has shown that people with diabetes are more likely to develop antibiotic-resistant strains of the bacterial infection Staphylococcus aureus.

A new automation track - one of the UK’s largest and most complex tracks for testing pathology samples - is being installed at the Centre for Laboratory Medicine (CfLM) at St James’s University Hospital in Leeds.

The next webinar in the ‘UKHSA Presents’ series will look at the recently launched metagenomics Surveillance Collaboration and Analysis Programme (mSCAPE) initiative.

Molecular diagnostics group Yourgene Health has announced the launch in the UK of IONA Care+, a fully comprehensive non-invasive prenatal screening service for genetic conditions.

Bioimaging firm Molecular Instruments has announced a significant advancement in dermatological diagnostics through the successful development and implementation of novel laboratory-developed tests (LDTs) at the Department of Dermatology at Yale School of Medicine.

Life sciences firm Fujifilm Irvine Scientific has entered into an agreement to sell its Medical Media Business Unit (MBU) to Astorg, a leading pan-European private equity firm with an extensive track record in global healthcare investments.

Using single cell analysis and spatial omics, a multi-national research team has shown in detail how multiple myeloma begins to spread in the body. The recently published results could contribute to more precise diagnostics and therapy, according to the study authors.

AliveDx has announced that its MosaiQ AiPlex CTDplus multiplex assay for the diagnosis and management of systemic autoimmune rheumatic diseases (SARDs) has received the IVDR-CE mark

A novel biomarker test developed at the University of Pittsburgh is able to detect Alzheimer's disease-related pathology earlier than other methods, a new study has discovered.

The Royal College of Pathologists (RCPath) has made a submission to Phase 2 of the Government's Spending Review, which will deliver the government’s ‘Plan for Change’, asking for investment in the pathology workforce, IT, and estates.

Registration is now open for the British Society for Microbial Technology’s annual conference, which is marking its 40th anniversary this year.

BD (Becton, Dickinson and Company) has announced a plan to separate BD's Biosciences and Diagnostic Solutions business from the rest of the company.

Precision medicine firm Oxford BioDynamics has announced the publication of compelling results involving its technology in a multi-centre study using blood to detect colorectal cancer (CRC), including early stage, and non-cancerous polyps with high accuracy.

Facility Monitoring Systems (FMS), a trusted provider of contamination control solutions, is excited to announce that it has joined Trescal, a global leader in calibration services.

Severn Pathology in Bristol has recently gone live with its fourth LIAISON XL system. What makes this one a bit more special is that it marks production of Diasorin’s 7,000th LIAISON XL instrument.

A new diagnostic test being trialled across eight NHS hospitals could transform how thyroid lumps are assessed, potentially sparing hundreds of patients from unnecessary surgery.